HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yongjun Wang Selected Research

Secondary Prevention

9/2022Prevalence and In-hospital outcomes of diabetes among acute ischemic stroke patients in china: results from the Chinese Stroke Center Alliance.
7/2022Clinical characteristics and prognosis in oldest old patients with ischaemic stroke or transient ischaemic attack in China.
1/2022Effect of Lipoprotein(a) on Stroke Recurrence Attenuates at Low LDL-C (Low-Density Lipoprotein) and Inflammation Levels.
1/2022Trends and Risk Factors Associated With Stroke Recurrence in China, 2007-2018.
1/2022Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
1/2022Family History is Related to High Risk of Recurrent Events after Ischemic Stroke or Transient Ischemic Attack.
1/2022Nontraditional Risk Factors for Residual Recurrence Risk in Patients with Ischemic Stroke of Different Etiologies.
12/2021Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA.
8/2021Barriers to medication adherence in a rural-urban dual economy: a multi-stakeholder qualitative study.
1/2021Residual Risk and Its Risk Factors for Ischemic Stroke with Adherence to Guideline-Based Secondary Stroke Prevention.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yongjun Wang Research Topics

Disease

260Stroke (Strokes)
11/2022 - 01/2006
192Ischemic Stroke
11/2022 - 01/2006
93Neoplasms (Cancer)
06/2022 - 05/2008
88Transient Ischemic Attack
11/2022 - 05/2008
36Hemorrhage
01/2022 - 06/2006
31Inflammation (Inflammations)
11/2022 - 01/2006
28Pathologic Constriction (Stenosis)
01/2022 - 01/2006
22Atherosclerosis
01/2022 - 09/2008
19Diabetes Mellitus
01/2022 - 05/2008
17Cerebral Hemorrhage
05/2022 - 05/2008
16Cardiovascular Diseases (Cardiovascular Disease)
11/2022 - 10/2013
15Insulin Resistance
03/2022 - 03/2005
15Atrial Fibrillation
01/2022 - 01/2013
13Neoplasm Metastasis (Metastasis)
01/2022 - 01/2015
12Hypertension (High Blood Pressure)
01/2022 - 05/2009
11Myocardial Infarction
01/2022 - 01/2015
10Cognitive Dysfunction
10/2022 - 09/2012
10Spinal Cord Injuries (Spinal Cord Injury)
05/2022 - 12/2010
10Hyperglycemia
01/2022 - 01/2015
10Infections
05/2021 - 07/2004
9Brain Ischemia (Cerebral Ischemia)
03/2022 - 12/2012
9Rheumatoid Arthritis
01/2022 - 08/2014
8Hematoma
11/2022 - 12/2011
8Alzheimer Disease (Alzheimer's Disease)
03/2022 - 12/2008
8Arthritis (Polyarthritis)
01/2022 - 03/2016
8Breast Neoplasms (Breast Cancer)
02/2021 - 08/2015
7Prediabetic State (Prediabetes)
08/2022 - 03/2012
7Embolic Stroke
12/2020 - 01/2013
7Obesity
01/2020 - 01/2009
7Peripheral Nerve Injuries
08/2019 - 09/2011
6Thrombosis (Thrombus)
06/2022 - 01/2014
6Cerebrovascular Disorders (Cerebrovascular Occlusion)
05/2022 - 11/2014
6Ischemia
01/2022 - 05/2008
6Crohn Disease (Crohn's Disease)
05/2021 - 08/2014
6Osteosarcoma (Osteogenic Sarcoma)
01/2021 - 07/2015
6Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2021 - 03/2015
6Carcinoma (Carcinomatosis)
05/2020 - 11/2010
6Pain (Aches)
03/2019 - 02/2011
6Ulcerative Colitis
05/2016 - 08/2014
5COVID-19
02/2022 - 01/2020
5Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2014
5Chronic Renal Insufficiency
01/2022 - 01/2014
5Hemorrhagic Stroke
10/2021 - 07/2013
5Pneumonia (Pneumonitis)
05/2021 - 08/2014

Drug/Important Bio-Agent (IBA)

68Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2022 - 01/2006
59Clopidogrel (Plavix)FDA Link
11/2022 - 09/2010
47Glucose (Dextrose)FDA LinkGeneric
08/2022 - 05/2008
34Pharmaceutical PreparationsIBA
01/2022 - 11/2008
28Biomarkers (Surrogate Marker)IBA
10/2022 - 11/2010
27TicagrelorIBA
01/2022 - 07/2016
24Tissue Plasminogen Activator (Alteplase)FDA Link
06/2022 - 02/2009
20oxidized low density lipoproteinIBA
11/2022 - 06/2011
20LipidsIBA
05/2022 - 04/2009
20Proteins (Proteins, Gene)FDA Link
04/2022 - 04/2009
19ProdrugsIBA
03/2022 - 11/2015
18C-Reactive ProteinIBA
11/2022 - 01/2013
18Cytochrome P-450 CYP2C19IBA
11/2022 - 07/2016
16Liposomes (Liposome)IBA
01/2022 - 05/2016
15danaparoid (Orgaran)FDA Link
01/2022 - 07/2010
14Triglycerides (Triacylglycerol)IBA
03/2022 - 01/2006
13CytokinesIBA
03/2022 - 01/2006
13Blood Glucose (Blood Sugar)IBA
01/2022 - 01/2012
12Doxorubicin (Adriamycin)FDA LinkGeneric
10/2021 - 06/2012
11LDL CholesterolIBA
11/2022 - 11/2014
11Interleukin-6 (Interleukin 6)IBA
06/2022 - 02/2014
11Hemoglobins (Hemoglobin)IBA
06/2022 - 02/2014
11Indicators and Reagents (Reagents)IBA
05/2022 - 01/2014
11Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2022 - 05/2008
11Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 05/2008
11Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 04/2013
11LigandsIBA
01/2021 - 07/2010
9CholesterolIBA
01/2022 - 09/2008
8Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2022 - 09/2010
8Insulin (Novolin)FDA Link
01/2022 - 03/2005
8Messenger RNA (mRNA)IBA
09/2020 - 11/2010
7Peptides (Polypeptides)IBA
01/2022 - 01/2013
7CateninsIBA
01/2022 - 08/2012
7AlbuminsIBA
01/2022 - 03/2015
7DisulfidesIBA
07/2021 - 01/2016
7Therapeutic UsesIBA
02/2021 - 05/2008
7MicroRNAs (MicroRNA)IBA
01/2019 - 09/2011
6Uric Acid (Urate)IBA
01/2022 - 03/2014
6CreatinineIBA
01/2022 - 01/2014
6HomocysteineIBA
12/2021 - 07/2010
6RNA (Ribonucleic Acid)IBA
01/2021 - 09/2013
5Macrophage Migration-Inhibitory FactorsIBA
05/2022 - 01/2017
5HDL LipoproteinsIBA
03/2022 - 12/2017
5SaponinsIBA
03/2022 - 12/2016
5Long Noncoding RNAIBA
01/2022 - 09/2017
5Irinotecan (Camptosar)FDA LinkGeneric
10/2021 - 02/2019
5Glutathione (Reduced Glutathione)IBA
07/2021 - 01/2016

Therapy/Procedure

152Therapeutics
11/2022 - 05/2008
35Secondary Prevention
09/2022 - 01/2006
18Thrombectomy
09/2022 - 06/2016
13Drug Therapy (Chemotherapy)
01/2022 - 05/2008
11Stents
10/2021 - 01/2006
8Length of Stay
01/2019 - 12/2011
6Remission Induction
07/2016 - 08/2014
5Immunotherapy
06/2022 - 09/2021
5Aftercare (After-Treatment)
05/2021 - 02/2009